Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at the Oppenheimer 23 rd Annual Healthcare Conference in December 2012. Details are below.
|PRESENTER:||Steve Gilman, EVP and Chief Scientific Officer|
|EVENT:||Oppenheimer 23 rd Annual Healthcare Conference|
|DATE:||Thursday, December 13, 2012|
|TIME:||10:35 a.m. Eastern Time|
|LOCATION:||The Waldorf Astoria, New York City|
Live audio with slide webcast can be accessed here.
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts